<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03793777</url>
  </required_header>
  <id_info>
    <org_study_id>Brainport_002</org_study_id>
    <nct_id>NCT03793777</nct_id>
  </id_info>
  <brief_title>The Effect of Aronia Melanocarpa Extract on Cognitive Function</brief_title>
  <official_title>The Effect of Short-term Aronia Melanocarpa Extract Supplementation on Cognitive Function in Healthy Young Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioActor B.V.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a great interest in improving cognitive performance, including memory and attention.&#xD;
      Improved attention is desirable for a large group of people because it is linked to improved&#xD;
      performance . Students and professionals can benefit from improved attention and thus&#xD;
      performance in academic and other work environments. In addition, cognitive functioning also&#xD;
      plays an important role in sports. Various cognitive skills, including attention, reaction&#xD;
      time and motor function, have shown that they can influence sport performance. A completely&#xD;
      natural supplement with aronia melanocarpa extract could be a promising way to naturally&#xD;
      improve cognitive performance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is a great interest in improving cognitive performance, including memory and attention.&#xD;
      Improved attention is desirable for a large group of people because it is linked to improved&#xD;
      performance. Students and professionals can benefit from improved attention and thus&#xD;
      performance in academic and other work environments. In addition, cognitive functioning also&#xD;
      plays an important role in sports. Various cognitive skills, including attention, reaction&#xD;
      time and motor function, have shown that they can influence sport performance. A completely&#xD;
      natural supplement with aronia melanocarpa extract could be a promising way to naturally&#xD;
      improve cognitive performance. The product in this study is aronia melanocarpa which contains&#xD;
      polyphenols. A limited number of clinical studies have already been carried out to see the&#xD;
      effect of similar products on cognitive functioning. However, these studies have often been&#xD;
      done in older study populations or over a longer period of time. In this study, in healthy&#xD;
      adolescents (ages between the 18-35 and with a BMI between 18.5 and 30), the investigators&#xD;
      want to test the short term (7 days) effect of aronia melanocarpa extract on cognitive&#xD;
      functioning. The investigators will also test the effect of supplementation on the&#xD;
      particpant's mood, vascular function, blood biomarkers, retinal vasculature, and subjective&#xD;
      cognition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 9, 2020</start_date>
  <completion_date type="Actual">April 29, 2021</completion_date>
  <primary_completion_date type="Actual">April 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Cross-over study with 2 intervention conditions</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>block randomization</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>After 7 days of supplementation</time_frame>
    <description>CANTAB</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mood</measure>
    <time_frame>After 7 days of supplementation</time_frame>
    <description>VAMS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers in blood and saliva</measure>
    <time_frame>After 7 days of supplementation</time_frame>
    <description>BDNF &amp; cortisol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular function</measure>
    <time_frame>After 7 days of supplementation</time_frame>
    <description>SBP &amp; DBP, PWA &amp; PWV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microvasculature</measure>
    <time_frame>After 7 days of supplementation</time_frame>
    <description>Fundus photography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective cognition</measure>
    <time_frame>After 7 days of supplementation</time_frame>
    <description>Cognitive Failures Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Cognitive Function</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>microcrystalline cellulose supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aronia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>aronia melanocarpa supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Aronia</intervention_name>
    <description>daily supplementation</description>
    <arm_group_label>Aronia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>daily supplementation</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy young adults: ages between 18 and 35&#xD;
&#xD;
          -  BM between 18.5-30 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current use of (antioxidant) dietary supplements and not willing to quit for the&#xD;
             duration of the study duration&#xD;
&#xD;
          -  Pre-existing or history of neurological illness&#xD;
&#xD;
          -  High blood pressure (&gt;140 systolic and/or &gt;90 diastolic mmHg)&#xD;
&#xD;
          -  Use of medication that might have influence on endpoints (e.g. antidepressant)&#xD;
&#xD;
          -  Known pregnancy or lactation&#xD;
&#xD;
          -  Food allergy to the study product&#xD;
&#xD;
          -  Administration of investigational drugs or participation in any scientific&#xD;
             intervention study which may interfere with this study, to be decided by the principle&#xD;
             investigator, in the 180 days prior to the study&#xD;
&#xD;
          -  Abuse of products (&gt; 20 alcoholic consumptions per week and drug usage)&#xD;
&#xD;
          -  Participation in a scientific intervention study which may interfere with this study&#xD;
             in the 180 days prior to this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jogchum Plat, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229ET</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 19, 2018</study_first_submitted>
  <study_first_submitted_qc>January 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 4, 2019</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>supplementation</keyword>
  <keyword>cognition</keyword>
  <keyword>cognitive function</keyword>
  <keyword>vascular function</keyword>
  <keyword>microvasculature</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

